Effect of siRNA-mediated inhibition of nuclear factor-κB in combination with 5-FU on apoptosis of squamous cell carcinoma cell lines

World Chinese Journal of Digestology

Volumn 16, Issue 16, 2008, Pages 1716-1721

  Tian, Fang ^a   Song, Min ^a   Xu, Pei Rong ^a   Liu, Hong Tao ^a   Xue, Le Xun ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

5 FU; Bcl 2; Esophageal squamous cell carcinoma; Nuclear factor kappa B; RNA interference

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; FLUOROURACIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOCORTIN 5; MESSENGER RNA; PROTEIN BNIP3; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STRUCTURE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; STAINING; WESTERN BLOTTING;

EID: 50849086132     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: 10.11569/wcjd.v16.i16.1716     Document Type: Article

References (30)

1. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83: 18-29
2. Wang J, Huang Q, Chen M. The role of NF-kappaB in hepatocellular carcinoma cell. Chin Med J (Engl) 2003; 116: 747-752
3. Qin JM, Wan XW, Zeng JZ, Wu MC. Effect of Sirpalpha1 on the expression of nuclear factor-kappa B in hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2007; 6: 276-283
4. Yu HG, Yu LL, Yang Y, Luo HS, Yu JP, Meier JJ, Schrader H, Bastian A, Schmidt WE, Schmitz F. Increased expression of RelA/nuclear factor-kappa B protein correlates with colorectal tumorigenesis. Oncology 2003; 65: 37-45
5. Yu LL, Yu HG, Yu JP, Luo HS, Xu XM, Li JH. Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human colorectal carcinoma tissue. World J Gastroenterol 2004; 10: 3255-3260
6. Nair A, Venkatraman M, Maliekal TT, Nair B, Karunagaran D. NF-kappaB is constitutively activated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix. Oncogene 2003; 22: 50-58
7. Im E, Choi SH, Suh H, Choi YH, Yoo YH, Kim ND. Synthetic bile acid derivatives induce apoptosis through a c-Jun N-terminal kinase and NF-kappaB-dependent process in human cervical carcinoma cells. Cancer Lett 2005; 229: 49-57
8. Bass BL. Double-stranded RNA as a template for gene silencing. Cell 2000; 101: 235-238
9. Caplen NJ, Parrish S, Imani F, Fire A, Morgan RA. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc Natl Acad Sci USA 2001; 98: 9742-9747
10. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494-498
11. Takahashi Y, Nishikawa M, Kobayashi N, Takakura Y. Gene silencing in primary and metastatic tumors by small interfering RNA delivery in mice: quantitative analysis using melanoma cells expressing firefly and sea pansy luciferases. J Control Release 2005; 105: 332-343
12. Chen LB, Xu JY, Yang Z, Wang GB. Silencing SMYD3 in hepatoma demethylates RIZI promoter induces apoptosis and inhibits cell proliferation and migration. World J Gastroenterol 2007; 13: 5718-5724
13. Tschaharganeh D, Ehemann V, Nussbaum T, Schirmacher P, Breuhahn K. Non-specific effects of siRNAs on tumor cells with implications on therapeutic applicability using RNA interference. Pathol Oncol Res 2007; 13: 84-90
14. Chinese source
15. Chinese source
16. Vaux DL, Korsmeyer SJ. Cell death in development. Cell 1999; 96: 245-254
17. Aggarwal BB, Ichikawa H. Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell Cycle 2005; 4: 1201-1215
18. Girdhani S, Bhosle SM, Thulsidas SA, Kumar A, Mishra KP. Potential of radiosensitizing agents in cancer chemo-radiotherapy. J Cancer Res Ther 2005; 1: 129-131
19. Fraser CC. Exploring the positive and negative consequences of NF-kappaB inhibition for the treatment of human disease. Cell Cycle 2006; 5: 1160-1163
20. Luo JL, Kamata H, Karin M. IKK/NF-kappaB signaling: balancing life and death - a new approach to cancer therapy. J Clin Invest 2005; 115: 2625-2632
21. Magné N, Toillon RA, Bottero V, Didelot C, Houtte PV, Gérard JP, Peyron JF. NF-kappaB modulation and ionizing radiation: mechanisms and future directions for cancer treatment. Cancer Lett 2006; 231: 158-168
22. Wang MH, Li YP, Wang XD, Zhang H, Xiong LH, Huang HZ. Correlation between serum p53 antibody and chemosensitivity in patient with esophageal cancer. Ai Zheng 2004; 23: 467-470
23. van Delft MF, Huang DC. How the Bcl-2 family of proteins interact to regulate apoptosis. Cell Res 2006; 16: 203-213
24. Kock N, Kasmieh R, Weissleder R, Shah K. Tumor therapy mediated by lentiviral expression of shBcl-2 and S-TRAIL. Neoplasia 2007; 9: 435-442
25. Fu GF, Lin XH, Han QW, Fan YR, Xu YF, Guo D, Xu GX, Hou YY. RNA interference remarkably suppresses bcl-2 gene expression in cancer cells in vitro and in vivo. Cancer Biol Ther 2005; 4: 822-829
26. Huang SL, Wu Y, Yu H, Zhang P, Zhang XQ, Ying L, Zhao HF. Inhibition of Bcl-2 expression by a novel tumor-specific RNA interference system increases chemosensitivity to 5-fluorouracil in Hela cells. Acta Pharmacol Sin 2006; 27: 242-248
27. Pozo-Guisado E, Merino JM, Mulero-Navarro S, Lorenzo-Benayas MJ, Centeno F, Alvarez-Barrientos A, Fernandez-Salguero PM. Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-kappaB. Int J Cancer 2005; 115: 74-84
28. Fahy BN, Schlieman MG, Mortenson MM, Virudachalam S, Bold RJ. Targeting BCL-2 overexpression in various human malignancies through NF-kappaB inhibition by the proteasome inhibitor bortezomib. Cancer Chemother Pharmacol 2005; 56: 46-54
29. Dolcet X, Llobet D, Pallares J, Matias-Guiu X. NF-kB in development and progression of human cancer. Virchows Arch 2005; 446: 475-482
30. Lee CH, Jeon YT, Kim SH, Song YS. NF-kappaB as a potential molecular target for cancer therapy. Biofactors 2007; 29: 19-35